Table 2.
This table lists nanoparticles currently known to induce or promote ferroptosis in the treatment of glioma.
| Classification | Compound | Mechanism |
|---|---|---|
| Nanoparticles | AMSNs | GSH depletion |
| LDL‐DHA | Loading natural omega 3 fatty acid | |
| ZVI NPs | Iron loadin | |
| FeGd-HN@Pt@LF/ | Increase intracellular Fe2+ and H2O2 levels |
|
| RGD2 | delivery system releasing Fe3+ and doxorubici |
|
| DGU : Fe/Dox | Consists of Fe3+ ion, tannic acid and sorafenib |
|
| SRF@FeIIITA | Increase intracellular | |
| PSAF NCs | Fe2+ levels | |
| MON‐p53 | Iron loading, inhibit SLC7A11 |